To view or add a comment, sign in Postmenopausal women represent a critically underrepresented patient population
The pattern problem: when occasional becomes habitual A single early dose is pharmacokinetically insignificant
From my research, GLP-1 medications don't necessarily 'speed up' your metabolism in the way some people might think, like burning more calories at rest
Your body is constantly adjusting water balance, glycogen stores, hormone levels, and how much energy it burns at rest
GLP-1RAs and SGLT-2is both have the ability to penetrate damaged basement membranes and tight junctions (Figure 5)
In other words, if the average person has a 50% chance of developing insulin resistance then patients with thyroid disease probably have about a 70% chance of having the same condition